⌘K

Aquestive Therapeutics, Inc. (AQST)

$5.20 5.05% $0.25 Healthcare

Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. The company's proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; and Exservan, an oral soluble film formulation of riluzole for the treatment of amyotrophic lateral sclerosis. Its proprietary pipeline of complex molecule products include AQST-108, a sublingual film formulation delivering systemic epinephrine for the treatment of conditions other than anaphylaxis; AQST-305, a sublingual film formulation of octreotide for the treatment of acromegaly; and AQST-109, an orally delivered epinephrine product candidate for the emergency treatment of allergic reactions, including anaphylaxis. Further, the company develops KYNMOBI, a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease. Aquestive Therapeutics, Inc. was incorporated in 2004 and is headquartered in Warren, New Jersey.

Market cap

$473.51M

CEO

Mr. Daniel Barber

Full time employees

157.00

Headquarters

Warren, NJ

IPO Date

Jul 25, 2018

Price-to-earnings (PE) Ratio

-14.44

Earnings-per-share (EPS)

$-0.36

Cash ratio (TTM)

6.47

Current ratio (TTM)

7.49

Net profit margin (TTM)

-44.07%

PE ratio (TTM)

-16.93

PEG ratio (TTM)

1.10

Price-to-book ratio (TTM)

-12.27

Price-to-sales ratio (TTM)

7.47

Quick ratio (TTM)

6.98

Return on assets (TTM)

-21.87%

Return on equity (TTM)

36.59%

Similar stocks (13)

Lantheus Holdings, Inc.

LNTH

$108.56 0.39% $0.42

Uptrend

Amphastar Pharmaceuticals, Inc.

AMPH

$50.09 0.62% $0.31

Neutral

Dynavax Technologies Corporation

DVAX

$11.50 2.59% $0.29

Downtrend

ANI Pharmaceuticals, Inc.

ANIP

$60.38 -1.10% $-0.67

Downtrend

Ironwood Pharmaceuticals, Inc.

IRWD

$4.51 -0.22% $-0.01

Downtrend

Organogenesis Holdings Inc.

ORGO

$2.93 2.81% $0.08

Downtrend

Alimera Sciences, Inc.

ALIM

$5.54 0.00% $0.00

Neutral

Lifecore Biomedical, Inc.

LFCR

$5.62 8.08% $0.42

Downtrend

Eagle Pharmaceuticals, Inc.

EGRX

$4.27 -0.23% $-0.01

Downtrend

Guardion Health Sciences, Inc.

GHSI

$10.85 3.63% $0.38

Neutral

Agile Therapeutics, Inc.

AGRX

$1.51 0.00% $0.00

Uptrend

Evoke Pharma, Inc.

EVOK

$4.44 4.72% $0.20

Downtrend

Shuttle Pharmaceuticals Holdings, Inc.

SHPH

$1.62 -2.41% $-0.04

Downtrend

ETF Exposure (24)

Invesco NASDAQ Future Gen 200 ETF

QQQS

0.753%

$27.51 1.81% $0.49

Uptrend

iShares Micro-Cap ETF

IWC

0.08424%

$126.54 2.19% $2.71

Uptrend

Vanguard Russell 2000 Value Index Fund

VTWV

0.02%

$150.33 1.93% $2.85

Uptrend

iShares Russell 2000 Value ETF

IWN

0.01781%

$170.39 1.83% $3.07

Uptrend

iShares Russell 2000 ETF

IWM

0.01265%

$223.97 2.06% $4.52

Uptrend

Vanguard Russell 2000 Growth Index Fund

VTWG

0.01%

$208.30 2.26% $4.61

Uptrend

Vanguard Russell 2000 Index Fund

VTWO

0.01%

$90.58 2.07% $1.84

Uptrend

iShares Russell 2000 Growth ETF

IWO

0.00684%

$285.77 2.18% $6.09

Uptrend

ProShares Ultra Russell2000

UWM

0.004652581196672061%

$44.09 4.26% $1.80

Uptrend

ProShares UltraPro Russell2000

URTY

0.0022936572415161905%

$54.27 6.25% $3.19

Uptrend

ProShares Hedge Replication ETF

HDG

0.0019439427570898766%

$50.07 0.41% $0.20

Uptrend

iShares Core S&P Total U.S. Stock Market ETF

ITOT

0.00128%

$125.25 1.78% $2.19

Uptrend

Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF

GSSC

$70.22 2.36% $1.62

Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

$49.43 -0.28% $-0.14

Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

$49.42 -0.28% $-0.14

Uptrend

Vanguard Balanced Index Fund

VBINX

$49.42 -0.26% $-0.13

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$136.02 0.03% $0.04

Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$96.13 -0.25% $-0.24

Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

$96.11 -0.25% $-0.24

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$134.99 -0.24% $-0.33

Uptrend

Vanguard Russell 3000 Index Fund

VTHR

$253.06 1.86% $4.61

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$282.05 1.69% $4.70

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$134.97 -0.24% $-0.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$182.92 2.00% $3.58

Uptrend

Similar stocks (13)

Lantheus Holdings, Inc.

LNTH

$108.56 0.39% $0.42

Uptrend

Amphastar Pharmaceuticals, Inc.

AMPH

$50.09 0.62% $0.31

Neutral

Dynavax Technologies Corporation

DVAX

$11.50 2.59% $0.29

Downtrend

ANI Pharmaceuticals, Inc.

ANIP

$60.38 -1.10% $-0.67

Downtrend

Ironwood Pharmaceuticals, Inc.

IRWD

$4.51 -0.22% $-0.01

Downtrend

Organogenesis Holdings Inc.

ORGO

$2.93 2.81% $0.08

Downtrend

Alimera Sciences, Inc.

ALIM

$5.54 0.00% $0.00

Neutral

Lifecore Biomedical, Inc.

LFCR

$5.62 8.08% $0.42

Downtrend

Eagle Pharmaceuticals, Inc.

EGRX

$4.27 -0.23% $-0.01

Downtrend

Guardion Health Sciences, Inc.

GHSI

$10.85 3.63% $0.38

Neutral

Agile Therapeutics, Inc.

AGRX

$1.51 0.00% $0.00

Uptrend

Evoke Pharma, Inc.

EVOK

$4.44 4.72% $0.20

Downtrend

Shuttle Pharmaceuticals Holdings, Inc.

SHPH

$1.62 -2.41% $-0.04

Downtrend

ETF Exposure (24)

Invesco NASDAQ Future Gen 200 ETF

QQQS

0.753%

$27.51 1.81% $0.49

Uptrend

iShares Micro-Cap ETF

IWC

0.08424%

$126.54 2.19% $2.71

Uptrend

Vanguard Russell 2000 Value Index Fund

VTWV

0.02%

$150.33 1.93% $2.85

Uptrend

iShares Russell 2000 Value ETF

IWN

0.01781%

$170.39 1.83% $3.07

Uptrend

iShares Russell 2000 ETF

IWM

0.01265%

$223.97 2.06% $4.52

Uptrend

Vanguard Russell 2000 Growth Index Fund

VTWG

0.01%

$208.30 2.26% $4.61

Uptrend

Vanguard Russell 2000 Index Fund

VTWO

0.01%

$90.58 2.07% $1.84

Uptrend

iShares Russell 2000 Growth ETF

IWO

0.00684%

$285.77 2.18% $6.09

Uptrend

ProShares Ultra Russell2000

UWM

0.004652581196672061%

$44.09 4.26% $1.80

Uptrend

ProShares UltraPro Russell2000

URTY

0.0022936572415161905%

$54.27 6.25% $3.19

Uptrend

ProShares Hedge Replication ETF

HDG

0.0019439427570898766%

$50.07 0.41% $0.20

Uptrend

iShares Core S&P Total U.S. Stock Market ETF

ITOT

0.00128%

$125.25 1.78% $2.19

Uptrend

Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF

GSSC

$70.22 2.36% $1.62

Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

$49.43 -0.28% $-0.14

Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

$49.42 -0.28% $-0.14

Uptrend

Vanguard Balanced Index Fund

VBINX

$49.42 -0.26% $-0.13

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$136.02 0.03% $0.04

Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$96.13 -0.25% $-0.24

Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

$96.11 -0.25% $-0.24

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$134.99 -0.24% $-0.33

Uptrend

Vanguard Russell 3000 Index Fund

VTHR

$253.06 1.86% $4.61

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$282.05 1.69% $4.70

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$134.97 -0.24% $-0.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$182.92 2.00% $3.58

Uptrend